News

Subscribe to our mailing list to receive research, advocacy and other updates from MS Australia

Categories
Categories
date range
date range

MS Australia News

25 September 2025

CEO Rohan Greenland shares five areas of special interest he’s watching closely as the world’s largest MS research congress, ECTRIMS, takes place in Barcelona….

25 September 2025

The International Progressive MS Alliance has collated MRI and clinical data from over 13,000 people to answer big questions in progressive MS….

25 September 2025

In this Q&A, Associate Professor Litza Kiropoulos discusses the connection between MS and mental health and her MS Australia-supported research aimed at improving quality of life….

23 September 2025

We are deeply saddened to learn that MS South Australia & Northern Territory (MS SA&NT) has entered into voluntary administration….

18 September 2025

The McDonald Diagnostic Criteria for MS have been updated to help people get diagnosed faster and more accurately….

18 September 2025

Updated international guidelines for diagnosing multiple sclerosis (MS) were published today, enabling earlier and more accurate diagnosis so people can begin treatment sooner and improve their long-term health outcomes….

2 September 2025

Reporting side effects, even minor ones, is one way people with MS can contribute to safer treatment for everyone….

27 August 2025

CEO Rohan Greenland details the upcoming handover of the Blueprint for a National Action Plan for Neurological Conditions, a prod to government to recognise both the obligation and the economic…

26 August 2025

A new Australian study shows COVID-19 boosters improve protection against new variants for people with MS, even when taking immune-suppressing treatments….

26 August 2025

People living with MS find MSReactor is a convenient and acceptable way to monitor changes in their thinking and memory over time….

22 August 2025

The Pharmaceutical Benefits Advisory Committee has recommended subcutaneous ocrelizumab (Ocrevus®) be listed on the PBS for treating relapsing remitting MS….

22 August 2025

The Government has announced changes to the NDIS aimed at slowing growth and making the scheme more sustainable. What are those changes and how will they impact Australians living with…

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Injectable form of Ocrevus® for relapsing remitting MS recommended for PBS listing